Philadelphia Pharmaceuticals Company (ASE:PHIL)
1.500
-0.010 (-0.66%)
At close: Apr 9, 2026
8.70% (1Y)
| Market Cap | 11.25M |
| Revenue (ttm) | 9.17M |
| Net Income (ttm) | 1.01M |
| Shares Out | 7.50M |
| EPS (ttm) | 0.13 |
| PE Ratio | 11.19 |
| Forward PE | n/a |
| Dividend | 0.07 (4.67%) |
| Ex-Dividend Date | Mar 30, 2026 |
| Volume | 1,000 |
| Average Volume | 402 |
| Open | 1.510 |
| Previous Close | 1.510 |
| Day's Range | 1.500 - 1.510 |
| 52-Week Range | 1.360 - 1.700 |
| Beta | -0.04 |
| RSI | 44.90 |
| Earnings Date | Apr 23, 2026 |